- Home
- SLNO vs STC Comparison
SLNO vs STC Comparison
Compare SLNO & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- STC
- Stock Information
- Founded
- SLNO 1999
- STC 1893
- Country
- SLNO United States
- STC United States
- Employees
- SLNO N/A
- STC N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- STC Specialty Insurers
- Sector
- SLNO Health Care
- STC Finance
- Exchange
- SLNO Nasdaq
- STC Nasdaq
- Market Cap
- SLNO 2.3B
- STC 2.0B
- IPO Year
- SLNO 2014
- STC N/A
- Fundamental
- Price
- SLNO $69.98
- STC $65.28
- Analyst Decision
- SLNO Strong Buy
- STC Buy
- Analyst Count
- SLNO 8
- STC 3
- Target Price
- SLNO $95.75
- STC $77.67
- AVG Volume (30 Days)
- SLNO 2.6M
- STC 170.2K
- Earning Date
- SLNO 05-08-2025
- STC 04-23-2025
- Dividend Yield
- SLNO N/A
- STC 3.06%
- EPS Growth
- SLNO N/A
- STC 135.13
- EPS
- SLNO N/A
- STC 2.61
- Revenue
- SLNO N/A
- STC $2,488,020,900.00
- Revenue This Year
- SLNO N/A
- STC $11.74
- Revenue Next Year
- SLNO N/A
- STC $12.55
- P/E Ratio
- SLNO N/A
- STC $25.01
- Revenue Growth
- SLNO N/A
- STC 10.11
- 52 Week Low
- SLNO $36.61
- STC $58.46
- 52 Week High
- SLNO $74.00
- STC $78.44
- Technical
- Relative Strength Index (RSI)
- SLNO 62.10
- STC 40.13
- Support Level
- SLNO $57.01
- STC $64.80
- Resistance Level
- SLNO $71.00
- STC $67.63
- Average True Range (ATR)
- SLNO 5.29
- STC 2.48
- MACD
- SLNO -0.08
- STC -0.40
- Stochastic Oscillator
- SLNO 76.34
- STC 32.16
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.